05.16.13
WIL Research is partnering with Three S Japan to represent its full portfolio of global safety assessment services in Japan. WIL Research offers technical and regulatory expertise in discovery support, product safety toxicological research, metabolism, bioanalytical chemistry, analytical chemistry, and formulation services. Three S Japan will represent these services through its extensive network of clients in the pharmaceutical and chemical industries.
“Three S Japan has a strong reputation serving the country’s pharmaceutical industry with high quality regulatory services underpinned by exceptional client focus,” said David Spaight, chairman and chief executive officer of WIL Research. “Through this partnership, clients will benefit from direct access to staff that can harness the full portfolio of WIL Research’s global services.”
Koichi Hagita, chief executive officer and president of Three S Japan, said, “WIL Research’s excellent reputation and our long-term client relationships and regulatory experience in the Japanese market will boost both our companies’ potential for growth.”
“Three S Japan has a strong reputation serving the country’s pharmaceutical industry with high quality regulatory services underpinned by exceptional client focus,” said David Spaight, chairman and chief executive officer of WIL Research. “Through this partnership, clients will benefit from direct access to staff that can harness the full portfolio of WIL Research’s global services.”
Koichi Hagita, chief executive officer and president of Three S Japan, said, “WIL Research’s excellent reputation and our long-term client relationships and regulatory experience in the Japanese market will boost both our companies’ potential for growth.”